New strategy could slash antibiotic overuse in sick kids

NCT ID NCT05975671

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tests whether a combination of clinical guidelines, feedback, and education can reduce the overuse of vancomycin in children with suspected sepsis in intensive care units. Over 52,000 patients and many clinicians across five hospitals will take part. The goal is to lower side effects like kidney damage and fight antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
behavioral intervention (clinical guidelines, feedback, and education)
What this could lead to
If successful, this could provide a proven way to reduce antibiotic overuse in pediatric ICUs, lowering the risk of kidney damage and antibiotic resistance.
What could go wrong
This is an early-stage behavioral study, not a drug trial. Results may vary across hospitals, and the intervention might not change prescribing habits as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL - INDUCED NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Healthcare of Atlanta

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19146, United States

  • Johns Hopkins Children's Center

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • St. Louis Children's Hospital

    RECRUITING

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.